Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection (Q31152445)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

15 October 2017

Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection (English)

1 reference

Europe PubMed Central

15 October 2017

0 references

anti-retroviral agent

0 references

Luis M Beltrán

object named as

Luis M Beltrán

1

0 references

Rafael Moreno-Luna

object named as

Rafael Moreno-Luna

11

0 references

Luis M Blanco-Colio

object named as

Luis M Blanco-Colio

8

0 references

object named as

Juan Antonio Moreno

12

0 references

5

object named as

Jesús Egido

1 reference

Europe PubMed Central

15 October 2017

author name string

Rocío Muñoz Hernández

2

1 reference

Europe PubMed Central

15 October 2017

Rebeca S de Pablo Bernal

3

1 reference

Europe PubMed Central

15 October 2017

José S García Morillo

4

1 reference

Europe PubMed Central

15 October 2017

Manuel Leal Noval

6

1 reference

Europe PubMed Central

15 October 2017

Sara Ferrando-Martinez

7

1 reference

Europe PubMed Central

15 October 2017

Miguel Genebat

9

1 reference

Europe PubMed Central

15 October 2017

José R Villar

10

1 reference

Europe PubMed Central

15 October 2017

language of work or name

0 references

publication date

4 March 2014

1 reference

Europe PubMed Central

15 October 2017

1 reference

Europe PubMed Central

15 October 2017

9

1 reference

Europe PubMed Central

15 October 2017

e90541

1 reference

Europe PubMed Central

15 October 2017

3

1 reference

Europe PubMed Central

15 October 2017

copyright license

Creative Commons Attribution 4.0 International

4 March 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Can early therapy reduce inflammation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Arterial inflammation in patients with HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Cardiovascular implications from untreated human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Association of C-reactive protein and HIV infection with acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

TWEAK and Fn14. New players in the pathogenesis of atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

21 June 2018

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0090541

21 January 2018

Documento de consenso de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2012)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3942443

31 October 2018

Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating sTWEAK improves the prediction of coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24594990

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0090541

1 reference

Europe PubMed Central

15 October 2017

2014PLoSO...990541B

0 references

1 reference

Europe PubMed Central

15 October 2017

1 reference

Europe PubMed Central

15 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31152445&oldid=1931726807"